Title: Rapid Reversal of CNS-Depressant Drug Effect prior to Brain Death Determination Investigators: Sameh Hanna, MD, Justin Atwood, MD Institution: Palmetto Health-University of South Carolina Medical Group, Division of Pulmonary, Critical Care and Sleep Medicine, Columbia, SC Save

Date Added
December 11th, 2018
PRO Number
Pro00077995
Researcher
Sameh Hanna

List of Studies

Keywords
Brain, Central Nervous System, Nervous System
Summary

Prospective trial with enrollment of 30 patients in various intensive care units at Palmetto Health Richland from January 1st 2019 to June 30th 2020. If patients had undergone targeted temperature management (33-36 degrees Celsius for 24 hours via intravascular or surface control methods, with or without sedation or neuromuscular blockade, followed by rewarming actively or passively at 0.25-0.5 degrees per hour over 8-12 hours to 37 degrees) investigators will wait 24 hours after rewarming prior to testing. End point is to evaluate if pharmacological reversal agents would result in improved GCS scores or return of cerebral or brainstem functions in some comatose patients, which will be considered a positive test result.

Institution
Palmetto
Recruitment Contact
Sameh Hanna
8643443439
sameh.hanna@palmettohealth.org

Change_preferences

-- OR --

Create_login